Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ |
| Upstream (Parents) |
|---|
| (<<) LOC652694///IGKV1-5///IGKC → IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ |
| (<<) LOC652493 → IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ |
| (<<) TRBC1 → IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ |
| Downstream (Children) |
|---|
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → ANAPC13 (>>) |
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → ZC3H15 (>>) |
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → AHI1 (>>) |
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → KIAA0125 (>>) |
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → IGLV2-18///IGLV3-19///IGL@ (>>) |
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → OXCT2 (>>) |
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → SPG20 (>>) |
| IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → CD79A (>>) |
